Endocrine function following treatment of pituitary adenoma.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma; D000324:Adrenocorticotropic Hormone; D000328:Adult; D001481:Basal Metabolism; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000175:diagnosis*; D008297:Male; D008797:Metyrapone; D010901:Pituitary Function Tests; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery*; D010912:Pituitary-Adrenal Function Tests; D011183:Postoperative Complications; D011859:Radiography
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone